Cel­gene/Re­cep­tos ex­ec jumps to Ku­ra as new COO; TG Ther­a­peu­tics al­lies with Novim­mune on $185M bis­pe­cif­ic deal

→ Ku­ra On­col­o­gy $KU­RA has re­cruit­ed a COO from Cel­gene. Ma­rine vet John Far­nam will leap in from the Cel­gene Re­cep­tos group in San Diego, which has been at the cen­ter of con­sid­er­able spec­u­la­tion in the wake of the FDA’s RTF let­ter for ozan­i­mod. Far­nam has been VP of Busi­ness Op­er­a­tions at the Cel­gene sub­sidiary. Brid­get Martell and Blake Tomkin­son have joined the com­pa­ny as Vice Pres­i­dents of Clin­i­cal De­vel­op­ment.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER